NVG, LLC for ASTELLAS PHARMA US, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 19, 2021 | $60,000 | Replaced |
| 4th Quarter - Amendment | Jan 21, 2021 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| LISA GERMAN FOSTER | — |
Health Issues HCR
Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895.
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| LISA GERMAN FOSTER | — |
| EDEN SHIFERAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.